Reports for NATCO PHARMA (CANADA) INC
Company Name
NATCO PHARMA (CANADA) INC
Totals |
||
Shortage reports |
56 |
|
| Actual shortage: | 30 (54%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 0 (0%) | |
| Resolved: | 26 (46%) | |
Discontinuation Reports |
10 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 10 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
1 (2%) |
|
Overdue reports |
1 (3%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| NAT-ONDANSETRON | 4MG | TABLET | Resolved | 2024-06-13 | 2025-07-21 | 230407 |
| NAT-PREGABALIN | 225MG | CAPSULE | Actual shortage | 2023-05-17 | 2024-11-01 | 192650 |
| NAT-QUETIAPINE | 25MG | TABLET | Resolved | 2018-10-31 | 2022-07-01 | 65944 |
| NAT-QUETIAPINE | 100MG | TABLET | Resolved | 2019-04-17 | 2022-07-01 | 81900 |
| NAT-QUETIAPINE | 150MG | TABLET | Resolved | 2019-04-23 | 2021-10-31 | 82236 |
| NAT-QUETIAPINE | 150MG | TABLET | Actual shortage | 2024-04-29 | 2025-07-03 | 226594 |
| NAT-QUETIAPINE | 200MG | TABLET | Resolved | 2019-04-17 | 2022-07-01 | 81903 |
| NAT-QUETIAPINE | 300MG | TABLET | Resolved | 2019-04-17 | 2022-07-01 | 81906 |
| NAT-RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-11-23 | 2019-02-07 | 67512 |
| NAT-RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Actual shortage | 2025-04-04 | 2025-07-03 | 254185 |
| NAT-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-11-23 | 2019-02-07 | 67515 |
| NAT-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Actual shortage | 2025-04-04 | 2025-07-03 | 254190 |
| NAT-ZOLMITRIPTAN | 2.5MG | TABLET | Resolved | 2024-07-29 | 2025-06-25 | 233895 |
| NAT-ZOLMITRIPTAN | 2.5MG | TABLET | Actual shortage | 2025-10-28 | 2025-10-29 | 270425 |
| NATCO-CITALOPRAM | 10MG | TABLET | Resolved | 2024-11-11 | 2024-11-12 | 242454 |
| NATCO-CITALOPRAM | 10MG | TABLET | Resolved | 2024-11-11 | 2024-11-12 | 242457 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| NAT-DONEPEZIL | 5MG | TABLET | Discontinued | 2025-12-05 | 2025-12-06 | 273383 |
| NAT-DONEPEZIL | 10MG | TABLET | Discontinued | 2025-12-05 | 2025-12-06 | 273387 |
| NAT-LEVETIRACETAM | 250MG | TABLET | Discontinued | 2025-12-05 | 2025-12-06 | 273390 |
| NAT-LEVETIRACETAM | 500MG | TABLET | Discontinued | 2025-12-05 | 2025-12-06 | 273434 |
| NAT-LEVETIRACETAM | 750MG | TABLET | Discontinued | 2025-12-05 | 2025-12-06 | 273437 |
| NAT-OMEPRAZOLE DR | 20MG | TABLET (DELAYED-RELEASE) | Discontinued | 2025-12-05 | 2025-12-06 | 273440 |
| NAT-QUETIAPINE | 25MG | TABLET (IMMEDIATE RELEASE) TABLET | Discontinued | 2025-12-05 | 2025-12-06 | 273482 |
| NAT-QUETIAPINE | 100MG | TABLET (IMMEDIATE RELEASE) TABLET | Discontinued | 2025-12-05 | 2025-12-06 | 273489 |
| NAT-QUETIAPINE | 200MG | TABLET (IMMEDIATE RELEASE) TABLET | Discontinued | 2025-12-05 | 2025-12-06 | 273496 |
| NAT-QUETIAPINE | 300MG | TABLET (IMMEDIATE RELEASE) TABLET | Discontinued | 2025-12-05 | 2025-12-06 | 273501 |
Showing 1 to 10 of 10